To examine the extent of joint damage and the progression of RA disease, we assessed serum levels of a set of fibrogenic markers including cartilage oligomeric matrix protein (COMP) and matrix metalloproteinases (MMP1 and MMP3). The gene discussed is MMP3; the disease is rheumatoid arthritis.